ALLO
Allogene Therapeutics, Inc.Company with tickers: ALLO
Market Cap
$711.02M
Shares Outstanding
345,154,561
CIK
1737287
CUSIP
019770106
13F Activity (30d)
2 filings
1 filers
Website
Visit website
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ALLO
131 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL OPPORTUNITY FUND | — | 5,364,570 | $13,089,551 | 0.05% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 5,212,606 | $12,718,759 | 0.17% | Long | 2026-03-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 4,879,191 | $11,905,226 | 0.00% | Long | 2026-03-31 | |
| iShares Russell 2000 ETF | — | 3,834,951 | $9,357,280 | 0.01% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 3,830,998 | $9,347,635 | 0.09% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 1,881,862 | $4,591,743 | 0.01% | Long | 2026-03-31 | |
| Select Biotechnology Portfolio | — | 1,401,115 | $3,895,100 | 0.07% | Long | 2026-02-28 | |
| abrdn Life Sciences Investors | HQL | 1,462,219 | $3,567,814 | 0.64% | Long | 2026-03-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 1,208,862 | $3,360,636 | 0.05% | Long | 2026-02-27 | |
| Nuveen Quant Small Cap Equity Fund | — | 1,565,200 | $3,333,876 | 0.09% | Long | 2026-04-30 | |
| iShares Russell 2000 Value ETF | — | 1,358,691 | $3,315,206 | 0.03% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 1,145,572 | $2,795,196 | 0.03% | Long | 2026-03-31 | |
| College Retirement Equities Fund - Total Global Stock Account | — | 989,626 | $2,414,687 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 868,066 | $2,413,223 | 0.01% | Long | 2026-02-28 | |
| Schwab U.S. Small-Cap ETF | — | 788,071 | $2,190,837 | 0.01% | Long | 2026-02-28 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 764,057 | $2,124,078 | 0.01% | Long | 2026-02-28 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 452,327 | $1,257,469 | 0.01% | Long | 2026-02-28 | |
| Fidelity Total Market Index Fund | — | 325,681 | $905,393 | 0.00% | Long | 2026-02-28 | |
| BlackRock Health Sciences Term Trust | BMEZ | 348,877 | $851,260 | 0.08% | Long | 2026-03-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 345,524 | $843,079 | 0.00% | Long | 2026-03-31 | |
| JPMorgan Small Cap Value Fund | — | 313,179 | $764,157 | 0.07% | Long | 2026-03-31 | |
| Schwab Small-Cap Index Fund | — | 340,989 | $726,307 | 0.01% | Long | 2026-04-30 | |
| Fidelity Series Total Market Index Fund | — | 233,054 | $647,890 | 0.00% | Long | 2026-02-28 | |
| Master Small Cap Index Series | — | 262,695 | $640,976 | 0.01% | Long | 2026-03-31 | |
| Ultra-Small Company Market Fund | — | 250,000 | $610,000 | 0.50% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 243,268 | $593,574 | 0.09% | Long | 2026-03-31 | |
| SMALL CAP EQUITY FUND | — | 213,000 | $519,720 | 0.06% | Long | 2026-03-31 | |
| Fidelity Small Cap Value Index Fund | — | 193,944 | $473,223 | 0.03% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 167,572 | $465,850 | 0.00% | Long | 2026-02-28 | |
| U.S. MICRO CAP PORTFOLIO | — | 205,690 | $438,120 | 0.01% | Long | 2026-04-30 | |
| EQ/2000 Managed Volatility Portfolio | — | 175,020 | $427,049 | 0.01% | Long | 2026-03-31 | |
| Virtus Biotech Clinical Trials Etf | — | 182,788 | $389,338 | 1.04% | Long | 2026-04-30 | |
| Schwab U.S. Broad Market ETF | — | 132,049 | $367,096 | 0.00% | Long | 2026-02-28 | |
| Nuveen Small Cap Blend Index Fund | — | 170,147 | $362,413 | 0.01% | Long | 2026-04-30 | |
| Nomura Healthcare Fund | — | 146,779 | $358,141 | 0.05% | Long | 2026-03-31 | |
| NVIT Multi-Manager Small Company Fund | — | 140,450 | $342,698 | 0.10% | Long | 2026-03-31 | |
| EQ/Small Company Index Portfolio | — | 140,441 | $342,676 | 0.02% | Long | 2026-03-31 | |
| VIP Disciplined Small Cap Portfolio | — | 134,268 | $327,614 | 0.06% | Long | 2026-03-31 | |
| Schwab Total Stock Market Index Fund | — | 148,999 | $317,368 | 0.00% | Long | 2026-04-30 | |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND | — | 111,827 | $310,879 | 0.03% | Long | 2026-02-28 | |
| Health Sciences Trust | — | 125,876 | $307,137 | 0.14% | Long | 2026-03-31 | |
| NVIT Small Cap Value Fund | — | 121,000 | $295,240 | 0.16% | Long | 2026-03-31 | |
| U.S. SMALL CAP PORTFOLIO | — | 131,123 | $279,292 | 0.00% | Long | 2026-04-30 | |
| BlackRock Health Sciences Trust | BME | 105,465 | $257,335 | 0.05% | Long | 2026-03-31 | |
| LVIP SSGA Small-Cap Index Fund | — | 93,800 | $228,872 | 0.01% | Long | 2026-03-31 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 92,282 | $225,168 | 0.14% | Long | 2026-03-31 | |
| VANGUARD BALANCED INDEX FUND | — | 89,181 | $217,602 | 0.00% | Long | 2026-03-31 | |
| JPMorgan Small Cap Value Portfolio | — | 84,135 | $205,289 | 0.07% | Long | 2026-03-31 | |
| BIOTECHNOLOGY ULTRASECTOR PROFUND | — | 94,053 | $200,333 | 0.11% | Long | 2026-04-30 | |
| Small Cap Index Fund | — | 77,171 | $188,297 | 0.01% | Long | 2026-03-31 |
Showing 1–50 of 131 positions